Preparation of active recombinant cathepsin K expressed in bacteria as inclusion body

被引:26
作者
Hwang, HS [1 ]
Chung, HS [1 ]
机构
[1] Hannam Univ, Dept Microbiol, Daeduk Ku, Taejon 306791, South Korea
关键词
inclusion body; refolding; autocatalysis; cathepsin K;
D O I
10.1016/S1046-5928(02)00033-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human cathepsin K (EC 3,4.22.38) is a member of the cysteine protease family with high primary sequence homology to cathepsins S, L, and B. It has been shown that cathepsin K plays a major role in the resorption of the bone matrix by osteoclasts. Cathepsin K has a potential as a drug target for the diseases related to bone matrix metabolism such as osteoporosis. We have expressed recombinant human procathepsin K in Escherichia coli as inclusion bodies, Purified procathepsin K had size of 38 kDa which is in agreement with the predicted mass of the construct. Refolding was done by rapid dilution into 50 mM Tris-HCl, pH 8.0 buffer containing 5 mM EDTA. 10 mM GSH, I mM GSSG, 0.7 M L-arginine, 0.5 M NaCl, and 1% CHAPS and further dialysis against 25 mM Tris-HCl, pH 8.0 containing 0.5 M NaCl. Mature active cathepsin K was prepared from refolded procathepsin K by incubating at 40 degreesC in pH 4.0 buffers with or without pepsin or cysteine. The presence of pepsin or cysteine in autocatalysis buffer did not have effect on the degree of conversion of nascent to mature cathepsin K, but reduced the autocatalysis time slightly. Proteolytic activity was confirmed using synthetic substrate, and Western blotting identified mature cathepsin K. Active cathepsin K had type I and II collagenolytic activities which could be inhibited by E-64. (C) 2002 Elsevier Science (USA), All rights reserved.
引用
收藏
页码:541 / 546
页数:6
相关论文
共 22 条
[1]  
Aibe K, 1996, BIOL PHARM BULL, V19, P1026
[2]   Mechanism of inhibition of cathepsin K by potent, selective 1,5-diacylcarbohydrazides: A new class of mechanism-based inhibitors of thiol proteases [J].
Bossard, MJ ;
Tomaszek, TA ;
Levy, MA ;
Ijames, CF ;
Huddleston, MJ ;
Briand, J ;
Thompson, S ;
Halpert, S ;
Veber, DF ;
Carr, SA ;
Meek, TD ;
Tew, DG .
BIOCHEMISTRY, 1999, 38 (48) :15893-15902
[3]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[4]   Selective removal of N-terminal methionine from recombinant human growth hormone by an aminopeptidase isolated from Aspergillus flavus [J].
Cho, MS ;
Lee, YP ;
Chung, HS .
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 1998, 20 (05) :287-290
[5]  
Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157
[6]   Expression in Escherichia coli, refolding, and purification of human procathepsin K, an osteoclast-specific protease [J].
D'Alessio, KJ ;
McQueney, MS ;
Brun, KA ;
Orsini, MJ ;
Debouck, CM .
PROTEIN EXPRESSION AND PURIFICATION, 1999, 15 (02) :213-220
[7]   Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J].
Drake, FH ;
Dodds, RA ;
James, IE ;
Connor, JR ;
Debouck, C ;
Richardson, S ;
LeeRykaczewski, E ;
Coleman, L ;
Rieman, D ;
Barthlow, R ;
Hastings, G ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12511-12516
[8]   COLLAGEN SUBSTRATA FOR STUDIES ON CELL BEHAVIOR [J].
ELSDALE, T ;
BARD, J .
JOURNAL OF CELL BIOLOGY, 1972, 54 (03) :626-&
[9]   EFFECTS OF THE PROTEINASE-INHIBITORS LEUPEPTIN AND E-64 ON OSTEOCLASTIC BONE-RESORPTION [J].
EVERTS, V ;
BEERTSEN, W ;
SCHRODER, R .
CALCIFIED TISSUE INTERNATIONAL, 1988, 43 (03) :172-178
[10]   Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency [J].
Gelb, BD ;
Shi, GP ;
Chapman, HA ;
Desnick, RJ .
SCIENCE, 1996, 273 (5279) :1236-1238